Fulminant Hepatic Failure clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 18 years and up
The purpose of this study is to collect clinical and epidemiological data as well as serum, plasma, urine, tissue and DNA samples on individuals who have acute liver failure and on individuals who have acute liver injury, a less severe group of patients who have coagulopathy but do not reach the threshold of encephalopathy.
San Francisco, California and other locations